Newer compounds in therapy of herpes simplex keratitis.
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003315:Cornea / Q000382:microbiology; D046508:Culture Techniques; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy* / Q000382:microbiology; D010919:Placebos; D011817:Rabbits; D018139:Simplexvirus / Q000302:isolation & purification; D013936:Thymidine / Q000627:therapeutic use* / Q000633:toxicity; D014529:Uridine / Q000627:therapeutic use*
D000998:Antiviral Agents; D010919:Placebos; D007065:Idoxuridine; D013936:Thymidine; D014529:Uridine